For example, in AD mouse models, rapamycin, a selective mTOR inhibitor delivered via exosomes, reduces mTOR activation, increases microtubule-associated protein 1 light chain 3-II (LC3-II) expression, and promotes neuronal autophagy 177. Here, MTOR is linked to Alzheimer disease.